Logo
ILLUMA PN Skin Booster Range

ILLUMA PN Skin Booster Range

iLLUMA

Injectable Skin Boosters
  • Marketed to professional aesthetic practitioners as a PN Based injectable skin booster; detailed device or product registrations (e.g. CE/UKCA, classification) are provided in the official product insert and technical documentation rather than in public marketing summaries.
  • Use is subject to local regulations governing injectable aesthetic treatments, including requirements for practitioner qualifications, consent, complication management and infection prevention.
Polynucleotide (PN) injectable skin booster

Description

iLLUMA PN Skin Booster (2 x 2.5ml), also referred to as iLLUMA PN Booster, is a premium polynucleotide (PN) injectable designed to strengthen the skin barrier, improve overall skin health and smooth visible signs of ageing. Each pre-filled syringe contains a powerful combination of polynucleotides, stabilised hyaluronic acid and two anti-ageing peptides, working together to nourish, hydrate and rejuvenate the skin. The formula delivers moisture to both the epidermis and dermis, stimulates collagen and elastin synthesis and supports local cellular immunity. It helps repair thin and damaged skin, reduces wrinkles, improves elasticity and tone and addresses pigmentation issues, providing a comprehensive skin-healing and anti-ageing effect. Supplied as 2 x 2.5 ml syringes for professional use, iLLUMA PN Skin Booster is suitable for full-face and neck treatment protocols carried out by trained practitioners.

Bnefits

  • Strengthens the skin barrier and overall skin structure, supporting healthier and more resilient skin.
  • Deeply hydrates and nourishes the epidermis and dermis, improving skin elasticity and comfort.
  • Reduces facial wrinkles and fine lines by stimulating collagen and elastin synthesis.
  • Tightens and firms the skin, enhancing tone and texture for a more youthful appearance.
  • Helps reduce pigmentation of various aetiologies, including post-traumatic hyperpigmentation, and supports more even skin tone.
  • Improves local cellular immunity, helping skin resist environmental and chemical stressors.
  • Combines PN, hyaluronic acid and two targeted peptides for a multi-mechanism anti-ageing effect in each treatment.
  • Provides a comprehensive skin-repair and skin-healing action suitable for mature or damaged skin.

Indications

  • Ageing skin with fine lines, wrinkles and loss of elasticity on the face and neck.
  • Compromised skin barrier, thin or damaged skin requiring structural support and repair.
  • Dehydrated or dull skin needing deep hydration and improved radiance.
  • Uneven skin tone and hyperpigmentation where PN-based boosters are appropriate.
  • Patients seeking a regenerative skin booster that targets collagen and elastin production alongside hydration.
  • Professional aesthetic protocols for full-face and neck revitalisation.

Composition

  • Polynucleotides (PN) – approximately 5 mg/ml: DNA/RNA fragments that strengthen skin structure, support cell immunity, reduce pigmentation and help protect against damage from chemicals and radiation.
  • Hyaluronic acid – approximately 12 mg/ml stabilised HA: provides deep hydration, an intradermal filler-like effect and a noticeable tightening and plumping of the skin for several days post-treatment.
  • Two anti-ageing peptides:
  • Acetyl hexapeptide-8 – peptide specifically designed to combat facial wrinkles, effectively reducing wrinkles on the neck and around the eyes and helping prevent new wrinkle formation.
  • Palmitoyl pentapeptide-4 – signal peptide that stimulates restoration of the structural elements of the dermis, including collagen, elastin, fibronectin and glycosaminoglycans.
  • Additional excipients and buffer components suitable for sterile injectable formulations (full technical ingredient list provided in the official iLLUMA PN Booster product insert and brochure).

Formulation

  • Injectable PN-based skin booster solution supplied in pre-filled 2.5 ml syringes.
  • Active complex of polynucleotides (PN), stabilised hyaluronic acid and two anti-ageing peptides.
  • Non-crosslinked, fluid skin booster intended for intradermal or superficial subdermal injection by trained professionals.
  • Designed for full-face and neck treatment, providing both biostimulatory and hydrating effects.

Packaging

  • Box containing 2 x 2.5 ml pre-filled syringes of iLLUMA PN Skin Booster (total 5 ml).
  • Each syringe is sterile, individually packed and labelled with product name, volume, batch number and expiry date.
  • Outer carton branded as iLLUMA PN Skin Booster / PN Booster, highlighting key ingredients (PN, HA, peptides) and main anti-ageing benefits.
  • Digital brochures and protocol documents are available from distributors for professional reference and training.

Usage

  • For professional use only; treatment must be performed by qualified medical or aesthetic practitioners trained in injectable skin boosters.
  • Take a full medical history, assess skin condition and rule out contraindications; obtain informed consent in line with clinic policy.
  • Cleanse and disinfect the treatment area (typically face and neck) using appropriate antiseptic measures and maintain aseptic technique throughout.
  • Use a sterile needle or cannula of suitable gauge as recommended in product protocols; draw or confirm the appropriate volume in the pre-filled syringe.
  • Inject intradermally or in the superficial subdermal plane using micro-papular, linear or mesotherapy-style techniques, distributing product evenly across the treatment area.
  • Typical treatment regimens described by distributors include approximately 1 treatment per month for 1–3 sessions, or series of 3–5 sessions every 2–3 weeks, followed by maintenance sessions every few months depending on patient response and protocol.
  • Adjust total volume per session (commonly 1–2 ml for full face/neck) based on indication, area size and individual patient needs, without exceeding recommended maximums.
  • After treatment, advise patients to avoid makeup on the treated area for the rest of the day, and to avoid excessive heat (saunas, steam rooms), intense exercise and direct sun exposure for at least 24–48 hours; recommend the use of broad-spectrum SPF.
  • Dispose of all used needles, cannulas and syringes immediately in approved sharps containers and handle remaining materials according to clinical waste regulations.

Contraindications

  • Known hypersensitivity or allergy to polynucleotides, hyaluronic acid, any of the included peptides or any other component of the formulation.
  • Active skin infections, inflammation, dermatitis or open lesions at the intended treatment site.
  • History of severe keloid or hypertrophic scarring in the planned treatment area.
  • Uncontrolled systemic diseases, significant autoimmune disorders or coagulation abnormalities unless carefully assessed and cleared by an appropriate medical professional.
  • Pregnancy and breastfeeding, as a precaution due to limited safety data for injectable PN skin boosters in these populations.
  • Use in individuals below the minimum age specified by local regulations and clinic policy (commonly under 18 years).
  • Any additional contraindications or precautions set out in the official iLLUMA PN Booster product insert, brochure or local clinical guidelines for injectable skin boosters.

Adverse Effects

  • Common injection-site reactions such as transient redness, swelling, tenderness, itching and bruising at treatment points, usually resolving within a few days.
  • Temporary papules or small lumps at intradermal injection points as the product disperses within the skin.
  • Rare risk of local infection or prolonged inflammation if aseptic technique or aftercare is inadequate.
  • Possible hypersensitivity or allergic reactions presenting as persistent erythema, oedema or pruritus.
  • As with any injectable facial treatment, a small risk of vascular compromise or inadvertent intravascular injection exists and requires prompt recognition and management by trained practitioners.
  • Potential post-inflammatory hyperpigmentation or transient textural changes, particularly in patients prone to PIH or with higher Fitzpatrick skin types.

Storage Conditions

  • Store in a cool, dry place at a stable temperature within the range specified in the product documentation (typically controlled room temperature; avoid extremes of heat or cold).
  • Keep syringes in their original packaging to protect from light, contamination and mechanical damage until immediately before use.
  • Do not freeze; avoid prolonged exposure to direct sunlight or high temperatures.
  • Do not use after the expiry date printed on the packaging or if the solution appears discoloured or contains particulate matter.
  • Once a syringe has been used, discard any remaining product; do not attempt to re-sterilise or reuse.

Duration

Typically delivered as a course of 1\u20133 sessions at roughly monthly intervals, or 3\u20135 sessions every 2\u20133 weeks, followed by maintenance treatments every 2\u20133 months as required; exact regimen is determined by the practitioner based on protocol and patient needs.

Onset

Hydration and radiance usually improve within days after treatment, while barrier strengthening, collagen and elastin stimulation, wrinkle reduction and pigmentation improvements develop progressively over several weeks and across the full treatment course.

Browse more Injectable Skin Boosters

Top Treatments

Top Cities in the UK